COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
By Maria Carvalho
At PCCA, we conduct extensive studies on the quality and safety of our proprietary products. We also collaborate with PCCA member pharmacies to conduct case studies that evaluate the efficacy of their compounded medications. We have been generating scientific evidence on pharmacy compounding for decades, and we want to share it publicly whenever possible. That’s why we created PCCA Science, a division within our Research & Development (R&D) department dedicated to writing our studies for publication.
To date, we have over 130 scientific publications, including peer-reviewed journal articles, conference abstracts and posters, technical reports, and case studies. These publications cover a broad range of therapeutic categories, such as aging, dermatology, gastroenterology, hormone replacement therapy, oncology, pain management, veterinary medicine, women’s health and wound therapy, among others. So that everyone can access our research related to pharmacy compounding and our proprietary products, we collected all of our studies on the PCCA Science webpage.
We have also attracted the interest of researchers and professionals worldwide who occasionally publish studies including our proprietary products. We regularly check scientific databases to search for these studies, and when we find them, we provide links to the corresponding journal articles on the PCCA Science webpage. As such, this page includes not only our R&D studies, but also those conducted by independent researchers.
Every month, we have new and exciting publications to share with the compounding community. We will periodically post updates about them on The PCCA Blog so that you don’t miss anything that could potentially be very useful for you, your patients or the health care practitioners you work with.
Below are our latest publications and research posters. Stay tuned for more PCCA Science updates.
• Budesonide 1-mg/10-mL and 2-mg/10-mL Mucolox Oral Suspensions A formulation published in the July/August 2018 issue of the International Journal of Pharmaceutical Compounding. Read the abstract here
• Basics of Sterile Compounding: Criteria for Determining Beyond-Use Dating An article published in the July/August 2018 issue of the International Journal of Pharmaceutical Compounding. Read the abstract here
• Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 An article published in the September/October 2018 issue of the International Journal of Pharmaceutical Compounding. Read the abstract here
• Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 An article published in the November/December 2018 issue of the International Journal of Pharmaceutical Compounding. Read the abstract here
• Case Study: Absorption of Testosterone Cream via Scrotal Delivery A case study published in the November/December 2018 issue of the International Journal of Pharmaceutical Compounding. Read the abstract here
• Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) A stability study published in the November/December 2018 issue of the International Journal of Pharmaceutical Compounding. Read the abstract here
• Physicochemical stability of omeprazole 2 mg/mL and 10 mg/mL oral suspensions in SuspendIt Presented at the 10th EuPFI Conference in London, United Kingdom, 12–13 September, 2018. Access the poster here • Physicochemical stability of lansoprazole 3 mg/mL and 10 mg/mL oral suspensions in SuspendIt Presented at the 10th EuPFI Conference in London, United Kingdom, 12–13 September, 2018. Access the poster here
Disease-Related Drooling Saliva in the Elderly (PCCA Sorbitol Lollipop) Published by PCCA Science. Access it here
Maria Carvalho, PharmD, MRPharmS, PhD, is the Manager of PCCA Science.